Targeted combinatiorial therapy for treatment of periodontal disease
牙周病的靶向联合治疗
基本信息
- 批准号:7660001
- 负责人:
- 金额:$ 21.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-20 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAddressAnimal ModelAntibodiesAreaBacteriaCanis familiarisChlorhexidineCollaborationsCommunitiesComplexConsultationsCoupledDevelopmentEngineeringEnhancersEquilibriumFamilyGeneticGingivaImmuneImmune systemIn VitroLifeMethodsMicrobial BiofilmsModalityModelingPeriodontal DiseasesPeriodontal InfectionPharmaceutical PreparationsPhotosensitizing AgentsProteinsResearchSchool DentistryStructureSurfaceSystemTestingTetracyclinesTissuesantimicrobialantimicrobial peptidebasebone losschemical geneticscombinatorialdesigneffective therapykillingsmembermicrobial communitynanonanomaterialsoxidationpathogenpublic health relevanceresearch studyresponsetool
项目摘要
DESCRIPTION (provided by applicant): An emerging concept is that the complex microbial communities that comprise periodontal consortia consist of both beneficial and pathogenic species. The implication is that periodontal disease can be treated by selectively eliminating putative pathogens, while minimizing the destruction of the commensal members of the community. We propose to engineer a family of nanoplatforms to target photosensitizers (PS) and PS/drug or antimicrobial peptide pairs to periodontal pathogens. We will test the hypothesis that the selective killing of targeted PS can be significantly enhanced by appropriate PS/drug or PS/antimicrobial peptide combinations. We will engineer nanoplatforms known as protein cages to implement our design strategy. In preliminary studies we have developed methods to target and kill biofilm-forming pathogens with protein cages functionalized with a photosensitizer (PS). In parallel, we developed a method for triggered release of a drug coupled to a protein cage. We will build upon this expertise to fabricate multifunctional nanoplatforms for targeted combinatorial therapy. The ability of our engineered nanoplatforms to selectively kill periodontal pathogens will be characterized in planktonic and established biofilm in vitro systems. We will determine which combinations of PS and enhancer are most effective in producing additive or synergistic killing of pathogens while maintaining selectivity. The specific aims (SA) are organized in terms of three combinations of treatment modalities: SA1) Targeted PS combined with non-targeted broad spectrum antimicrobials; SA2) Targeted PS combined with targeted triggered release of two types of broad spectrum antimicrobials and SA3) Targeted PS combined with an antimicrobial peptide. The strength of our research team lies in the combined expertise of two centers: the Center for BioInspired Nanomaterials and the Center for Biofilm Engineering. We have specifically designed the experiments so that the most promising systems can be tested in an animal model of periodontal disease.
PUBLIC HEALTH RELEVANCE: The bone loss and tissue destruction that accompany periodontal disease are caused by the response of the immune system to bacteria. However, we know that the immune system can live in harmony with many types of bacteria. Our research will provide a tool to selectively eliminate bacteria suspected of causing immune malfunction while sparing bacteria thought to be beneficial.
描述(由申请人提供):一个新兴的概念是,组成牙周聚生体的复杂微生物群落由有益和致病物种组成。这意味着牙周病可以通过选择性地消除假定的病原体来治疗,同时最大限度地减少对社区成员的破坏。我们建议设计一系列纳米平台,以将光敏剂(PS)和PS/药物或抗菌肽对靶向牙周病原体。我们将检验这样的假设,即通过适当的PS/药物或PS/抗微生物肽组合可以显著增强靶向PS的选择性杀伤。我们将设计被称为蛋白质笼的纳米平台来实施我们的设计策略。在初步研究中,我们已经开发出了用光敏剂(PS)功能化的蛋白质笼靶向和杀死生物膜形成病原体的方法。与此同时,我们开发了一种用于触发释放与蛋白质笼偶联的药物的方法。我们将建立在这方面的专业知识,以制造多功能的纳米平台,有针对性的组合治疗。我们的工程纳米平台选择性杀死牙周病原体的能力将在体外系统中以牙周炎和已建立的生物膜为特征。我们将确定PS和增强剂的哪种组合在保持选择性的同时最有效地产生病原体的相加或协同杀灭。具体目标(SA)按照三种治疗方式的组合进行组织:SA 1)靶向PS与非靶向广谱抗菌剂组合; SA 2)靶向PS与两种类型广谱抗菌剂的靶向触发释放组合; SA 3)靶向PS与抗菌肽组合。我们研究团队的优势在于两个中心的专业知识:生物启发纳米材料中心和生物膜工程中心。我们专门设计了实验,以便最有前途的系统可以在牙周病的动物模型中进行测试。
公共卫生关系:牙周病是一种常见的牙周病,是由牙周病引起的牙周病。然而,我们知道免疫系统可以与许多类型的细菌和谐相处。我们的研究将提供一种工具,选择性地消除被怀疑导致免疫功能障碍的细菌,同时保留被认为有益的细菌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK j YOUNG其他文献
MARK j YOUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK j YOUNG', 18)}}的其他基金
Small molecular weight targeted killing agents against a periodontal pathogen
针对牙周病原菌的小分子量靶向杀灭剂
- 批准号:
8583754 - 财政年份:2013
- 资助金额:
$ 21.38万 - 项目类别:
Small molecular weight targeted killing agents against a periodontal pathogen
针对牙周病原菌的小分子量靶向杀灭剂
- 批准号:
8740477 - 财政年份:2013
- 资助金额:
$ 21.38万 - 项目类别:
VIRUS BASED BIO-IMAGING & THERAPEUTIC DELIVERY SYSTEMS
基于病毒的生物成像
- 批准号:
6520256 - 财政年份:2000
- 资助金额:
$ 21.38万 - 项目类别:
VIRUS BASED BIO-IMAGING & THERAPEUTIC DELIVERY SYSTEMS
基于病毒的生物成像
- 批准号:
6094647 - 财政年份:2000
- 资助金额:
$ 21.38万 - 项目类别:
VIRUS BASED BIO-IMAGING & THERAPEUTIC DELIVERY SYSTEMS
基于病毒的生物成像
- 批准号:
6387166 - 财政年份:2000
- 资助金额:
$ 21.38万 - 项目类别:
ENDOTHELIAL CONTROL OF LARGE CORONARY ARTERY VASOACTIVI
大冠状动脉血管活性的内皮控制
- 批准号:
3448920 - 财政年份:1985
- 资助金额:
$ 21.38万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 21.38万 - 项目类别:
Research Grant














{{item.name}}会员




